Search results
British Thoracic Society Guideline for bronchiectasis in adults Adam T Hill, 1 Anita L Sullivan,2 James D Chalmers,3 Anthony De Soyza,4 J Stuart Elborn,5 R Andres Floto,6,7 Lizzie Grillo,8 Kevin Gruffydd-Jones,9 Alex Harvey,10 Charles S Haworth,7 Edwin Hiscocks,11 John R Hurst,12 Christopher Johnson,7 W Peter Kelleher,13,14,15 Pallavi Bedi,16 Karen Payne,17
Treatment for bronchiectasis aims to reduce chest infections and symptoms, improve quality of life and lower a person’s likelihood of complications, like reduced lung function.
28 gru 2018 · Use of bronchodilators in patients with bronchiectasis and coexisting COPD or asthma should follow the guideline recommendations for COPD or asthma (D). Offer a trial of long-acting bronchodilator therapy in patients with symptoms of significant breathlessness (D).
manage very well living with bronchiectasis. What is the treatment for bronchiectasis? Treatment for bronchiectasis aims to prevent further damage and infection in your lungs and reduce your symptoms. You’ll be given: • a personalised self-management plan to help you control your symptoms
The ACC/AHA Joint Committee on Clinical Practice Guidelines has commissioned this guideline to focus on the evaluation of acute or stable chest pain or other anginal equivalents, in various clinical settings, with an emphasis on the diagnosis on ischemic causes.
Treating Bronchiectasis. Bronchiectasis (bron-kee-eck-tuh-sis) is a lung condition that causes cough, sputum production, and recurrent respiratory infections. (Also see “What is Bronchiectasis?” at www.thoracic.org/patients). Because bronchiectasis is a condition that develops over many years
The new British Thoracic Society (BTS) Guideline for Bronchiectasis in Adults has been published. This article provides a summary of key highlights of the new BTS Guideline and covers who to investigate, what investigations should be carried out and a management strategy.
